LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday

Alvotech, Advanz Pharma File AVT29 Line Extension To Mynzepli Marketing Authorization With EMA For Proposed Eylea 8mg Biosimilar

Alvotech And LOTTE Biologics Announce Long-Term Strategic Manufacturing Partnership For Biosimilar Products

Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics’ Syracuse facility in New YorkStrategic long-term partnership to increase Alvotech’s global manufacturing capacity and support

Alvotech shares are trading higher after the company announced FDA approval for additional U.S. manufacturing capacity for SIMLANDI.

Alvotech Gets FDA Nod For Added US Manufacturing Capacity For Humira Biosimilar SIMLANDI, Doubling Drug Substance Capacity At Reykjavik Site

Approval enables AVT02 drug substance for U.S. commercial supply to be manufactured in either of Alvotech’s two Reykjavik drug substance suitesFurther confirms resolution of FDA inspection-related matters at the

Shares of semiconductor and chip companies are trading lower as rising inflation concerns and elevated energy prices fuel expectations for further Fed rate hikes. Elevated borrowing costs could pressure semiconductor manufacturing and AI infrastructure investments while straining customer budgets. The Philadelphia Semiconductor Index (SOX) has declined for seven consecutive trading sessions, matching its longest losing streak since the 2008 financial crisis.

Shares of semiconductor and chip companies are trading lower as rising inflation concerns and elevated energy prices fuel expectations for further Fed rate hikes. Rising borrowing costs could pressure fab and AI infrastructure while straining customers budgets. Semiconductor stocks also faced pressure after South Korea’s Kospi index fell more than 7% overnight.